Requirement of p27(Kip1) for restriction point control of the fibroblast cell cycle

被引:643
|
作者
Coats, S
Flanagan, WM
Nourse, J
Roberts, JM
机构
[1] GILEAD SCI,FOSTER CITY,CA 94404
[2] STANFORD UNIV,SCH MED,PROGRAM CANC BIOL,STANFORD,CA 94305
关键词
D O I
10.1126/science.272.5263.877
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Cells deprived of serum mitogens will either undergo immediate cell cycle arrest or complete mitosis and arrest in the next cell cycle. The transition from mitogen dependence to mitogen independence occurs in the mid- to late G(1) phase of the cell cycle and is called the restriction point. Murine Balb/c-3T3 fibroblasts deprived of serum mitogens accumulated the cyclin-dependent kinase (CDK) inhibitor p27(Kip1). This was correlated with inactivation of essential G(1) cyclin-CDK complexes and with cell cycle arrest in G(1). The ability of specific mitogens to allow transit through the restriction point paralleled their ability to down-regulate p27, and antisense inhibition of p27 expression prevented cell cycle arrest in response to mitogen depletion. Therefore, p27 is an essential component of the pathway that connects mitogenic signals to the cell cycle at the restriction point.
引用
收藏
页码:877 / 880
页数:4
相关论文
共 50 条
  • [1] Translational control of p27(Kip1) accumulation during the cell cycle
    Hengst, L
    Reed, SI
    SCIENCE, 1996, 271 (5257) : 1861 - 1864
  • [2] Expression of cell cycle inhibitor p27 Kip1 in nevi and melanomas
    Akman, Ayse
    Ciftcioglu, M. Akif
    Ozbey, Caner
    Alpsoy, Erkan
    INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2008, 74 (05):
  • [3] Mutational analysis of the cell cycle inhibitor Kip1/p27 in childhood leukemia
    Markaki, E. -A.
    Stiakaki, E.
    Zafiropoulos, A.
    Arvanitis, D. A.
    Katzilakis, N.
    Dimitriou, H.
    Spandidos, D. A.
    Kalmanti, M.
    PEDIATRIC BLOOD & CANCER, 2006, 47 (01) : 14 - 21
  • [4] A role for p27/Kip1 in the control of cerebellar granule cell precursor proliferation
    Miyazawa, K
    Himi, T
    Garcia, V
    Yamagishi, H
    Sato, S
    Ishizaki, Y
    JOURNAL OF NEUROSCIENCE, 2000, 20 (15): : 5756 - 5763
  • [5] Expression of the cell cycle regulator p27 kip1 in Saudi bladder cancer patients
    Nedjadi, T.
    Asayyad, A.
    Khayyat, D.
    Salem, N.
    Alammari, A.
    Al-Maghrabi, J.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S506 - S506
  • [6] Prognostic value and functional consequences of cell cycle inhibitor p27 Kip1 loss in medulloblastoma
    Hatton B.A.
    Ellison D.W.
    Gajjar A.
    Kool M.
    Fero M.
    Olson J.M.
    Biomarker Research, 1 (1)
  • [7] Expression of p27(KIP1) and cell proliferation in human retina and retinoblastoma
    Kase, S
    Yoshida, K
    Ohgami, K
    Shiratori, K
    Harada, T
    Ohno, S
    ANTICANCER RESEARCH, 2005, 25 (6B) : 3843 - 3846
  • [8] p27/kip1 expression in human astrocytic gliomas
    Piva, R
    Cavalla, P
    Bortolotto, S
    Cordera, S
    Richiardi, P
    Schiffer, D
    NEUROSCIENCE LETTERS, 1997, 234 (2-3) : 127 - 130
  • [9] Phosphorylation of p27(KIP1) in the developing retina and retinoblastoma
    Kase, S
    Yoshida, K
    Nakayama, KI
    Nakayama, K
    Ikeda, H
    Harada, T
    Harada, C
    Ohgami, K
    Shiratori, K
    Ohno, S
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2005, 16 (02) : 257 - 262
  • [10] p27/Kip1 mutation found in breast cancer
    Spirin, KS
    Simpson, JF
    Takeuchi, S
    Kawamata, N
    Miller, CW
    Koeffler, HP
    CANCER RESEARCH, 1996, 56 (10) : 2400 - 2404